ADTX Aditxt Corp: Forvard P/S multiplikatori
Aditxt biotexnologiya startaplari bilan birlashishlar orqali o'z ekotizimini kengaytirmoqda, biroq kritik likvidlik tanqisligi va ortib borayotgan qarzlar holding kompaniyasining barqarorligiga tahdid solmoqda. GURU.Markets terminali ma'lumotlari hisoblangan forward P/S ko'rsatkichini taqdim etadi, bunda 1017.10 ko'rsatkichi maqsadli daraja vazifasini o'taydi. Shu bilan birga, immun monitoringi sohasidagi patentlar Aditxt kompaniyasiga klinik yordamchi xizmatlar orqali intellektual mulkni monetizatsiya qilish imkoniyatini beradi.
aditxt.com (ADTX) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Aditxt|ADTX - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aditxt, Inc.|ADTX - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Aditxt, Inc.|ADTX - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Aditxt|Tezkor likvidlik koeffitsiyenti aditxt.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ADTX - Kompaniya foydasi|Kelajakdagi foyda Aditxt|ADTX - Bozor narxining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Aditxt, Inc.|ADTX - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Aditxt, Inc.|ADTX - Foizlar, soliqlar, eskirish va amortizatsiya chegirilmasdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Aditxt|ADTX - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi aditxt.com|ADTX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Aditxt
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:Aditxt Corp (ADTX)
Pears platformasining transplantatsiya paytida immun rad etishini monitoring qilishdagi samaradorligi Aditxt kompaniyasining daromad o'sish sur'atlarini belgilaydi, bu esa bozor kapitalizatsiyasining kutilayotgan savdolarga nisbati sifatida forward P/S ko'rsatkichiga bevosita ta'sir qiladi. Aditxt forward P/S grafigini tahlil qilish orqali investor kelajakdagi daromadlar uchun to'lovning haddan tashqari yuqoriligini baholaydi va past baholangan aktivga kirish nuqtalarini aniqlash uchun koeffitsiyentlar siqilishi (multiple compression) usulidan foydalanadi.
Raqobatdosh kompaniyalar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|PTGX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|KNSA (Kiniksa) - Forvard P/S multiplikatori|Grifols SA (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Narxning kutilayotgan daromadga nisbati CLDX|Aurinia Pharmaceuticals - Forvard narx/daromad multiplikatori|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Dianthus Therapeutics Inc - Narxning kutilayotgan daromadga nisbati|PHVS: Forvard P/S multiplikatori|AbCellera Corp (ABCL) - Forvard P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (precigen.com)|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|Narxning kutilayotgan daromadga nisbati NKTR|Upstream Bio Corp - Forvard narx/daromad multiplikatori|ZBIO: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati GOSS|KALV: Forvard P/S multiplikatori|Septerna, Inc. - Sotuvga nisbatan forvard narx|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Savara Pharma|Narxning prognoz qilingan daromadga nisbati Rigel Pharmaceuticals (RIGL)|ANAB (anaptysbio.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|ENGN - Forvard narx/daromad multiplikatori|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|JBIO - Forvard P/S multiplikatori|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|kyvernatx.com - Sotuvga nisbatan forvard narx|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Forvard narx/daromad multiplikatori Theratechnologies, Inc THTX|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|ELDN - Forvard narx/daromad multiplikatori|AGEN: Forvard narx/daromad multiplikatori|CLYM - Forvard P/S multiplikatori|Zura Bio Limited (ZURA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATYR|ADAG (Adagene Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ikena Oncology, Inc. IMA|Forvard P/S multiplikatori STTK|Forvard P/S multiplikatori equilliumbio.com (EQ)|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|IMUX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Atara Biotherapeutics Inc - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati InflaRx N.V. IFRX|XFOR (X4 Pharmaceuticals, Inc.) - Forvard narx/daromad multiplikatori|ACET: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori CELU|Kapitalizatsiyaning prognoz qilingan daromadga nisbati INMB (INmune Bio Corporation)|Forvard narx/daromad multiplikatori BRNS (Barinthus Biotherapeutics)|Narxning kutilayotgan daromadga nisbati KZR|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Forvard P/S multiplikatori Akari Therapeutics PLC AKTX|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|QTTB (Q32 Bio Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|GOVX (GeoVax Labs, Inc.) - Forvard narx/daromad multiplikatori|EDSA: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori IBIO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CARM (Carisma Tx)|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|BOLT: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori HCWB (HCW Biologics)|Sotuvga nisbatan forvard narx APVO|AIM ImmunoTech - Forvard P/S multiplikatori|GRI - Forvard P/S multiplikatori|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Vyome Therapeutics - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Forvard narx/daromad multiplikatori indaptusrx.com (INDP)|Forvard P/S multiplikatori SCNI|Forvard P/S multiplikatori calcimedica.com (CALI)|Affimed N.V. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ALLK|HOOKIPA - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Ocean Biomedical Inc|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard narx/daromad multiplikatori Third Harmonic Bio Inc (THRD)
